The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
Senior scientist Nallathamby Kalaiselvi has been appointed as the Director General of the Council of Scientific and Industrial Research (CSIR), for two years.